72 results
Page 3 of 4
8-K
EX-99.1
0samvy
3 Apr 23
Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results
5:21pm
8-K
EX-99.1
yv0g vssgencc
21 Dec 22
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
4:30pm
8-K
EX-99.1
eeb18xtju4nv
30 Nov 22
Regulation FD Disclosure
8:00am
424B4
sdngphh00hm2qx
14 Oct 22
Prospectus supplement with pricing info
5:16pm
8-K
EX-99.1
gng9h4 r8jw9cpekh
14 Oct 22
Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering
8:30am
S-1
7z4e7lp
13 Sep 22
IPO registration
5:24pm
8-K
EX-99.1
28yxo93n
14 Jul 22
Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
4:05pm
8-K
EX-99.1
a49z4m3frz81hrj4po
11 Jul 22
Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
4:05pm
8-K
EX-99.1
0zg6ceihkx
23 Jun 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
drr hle2r3c7p8
26 Apr 22
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
8:00am
8-K
EX-99.1
exlfl8rk36 z7j5wr
13 Apr 22
Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
4:05pm
8-K
EX-99.1
54ysxpopf0z55kqnjp85
7 Apr 22
Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
8:00am
8-K
EX-99.1
943nd38s1 gnwe73m
29 Mar 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
yuq7kx6
24 Mar 22
Novo Integrated Sciences’ PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
8:00am
8-K
EX-99.1
3w3xtdryuv281
23 Mar 22
Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
8:00am
8-K
EX-99.1
zv27bibpa73ds872r44
16 Mar 22
Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by
8:00am